Oviva has secured $80 million in Series C funding, co-led by Sofina and Temasek, to expand its digital health coaching services across Europe.
Information on the Target
Oviva is a digital health scaleup founded in 2014 that specializes in providing dietary and lifestyle coaching for individuals facing diet-related health challenges. The company aims to empower its users by helping them change their eating habits, which contributes to better long-term health and overall wellbeing. Oviva utilizes a combination of personalized coaching and an intuitive mobile application to facilitate this transformation, employing only certified dietitians to ensure compliance with health system regulations.
The innovative approach taken by Oviva not only benefits individuals but also integrates with health insurance systems, making its services accessible and financially feasible for users. This allows Oviva to reach a broader audience while maintaining a focus on quality and effectiveness in dietary management.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The digital health market in Europe is experiencing significant growth, fueled by the increasing prevalence of lifestyle-related diseases and rising healthcare costs. The shift towards preventive health measures has encouraged individuals to seek out
Similar Deals
Lotus Pharmaceutical Co., Ltd. → LENZ Therapeutics, Inc.
2025
Mérieux NutriSciences → food testing business of Bureau Veritas
2024
Hikma Pharmaceuticals PLC → Takeda Pharmaceuticals International AG
2024
Sofina, Temasek, AlbionVC, Earlybird, Eight Roads Ventures, F-Prime Capital, MTIP, Various angel investors
invested in
Oviva
in 2023
in a Other deal
Disclosed details
Transaction Size: $80M